Industry News
Wanbangde’s MCR Cyclic Peptide Outperforms GLP-1 in Weight Loss, Bringing New Breakthroughs for Metabolic Diseases.
On September 29, 2025, Wanbangde Biotech announced that its independently developed MCR cyclic peptide has shown superior weight-loss and metabolic regulation effects compared to existing GLP-1 drugs in preclinical studies.
